Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10011228HBVENSG00000171608.18protein_codingPIK3CDYesNo5293O00329
TVIS30005072HIVENSG00000171608.18protein_codingPIK3CDYesNo5293O00329
TVIS30005073HIVENSG00000171608.18protein_codingPIK3CDYesNo5293O00329
TVIS30001457HIVENSG00000171608.18protein_codingPIK3CDYesNo5293O00329
TVIS30011160HIVENSG00000171608.18protein_codingPIK3CDYesNo5293O00329
TVIS30014456HIVENSG00000171608.18protein_codingPIK3CDYesNo5293O00329
TVIS30011161HIVENSG00000171608.18protein_codingPIK3CDYesNo5293O00329
TVIS30005074HIVENSG00000171608.18protein_codingPIK3CDYesNo5293O00329
TVIS30001458HIVENSG00000171608.18protein_codingPIK3CDYesNo5293O00329
TVIS30011162HIVENSG00000171608.18protein_codingPIK3CDYesNo5293O00329
TCGA Plot Options
Drug Information
GenePIK3CD
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0002406
UniProt IDO00329
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830